Milestone Scientific (NYSE:MLSS) Trading 3.1% Higher – Here’s What Happened

Milestone Scientific Inc. (NYSE:MLSS) rose 3.1% during mid-day trading on Thursday . The company traded as high as $0.3685 and last traded at $0.3551. Approximately 203,137 shares were traded during trading, a decline of 55% from the average daily volume of 455,711 shares. The stock had previously closed at $0.3445.

Wall Street Analysts Forecast Growth

Separately, Benchmark cut their target price on shares of Milestone Scientific from $1.25 to $1.00 and set a “speculative buy” rating for the company in a research report on Thursday, November 20th. One analyst has rated the stock with a Buy rating, Based on data from MarketBeat.com, Milestone Scientific presently has a consensus rating of “Buy” and an average target price of $1.00.

Milestone Scientific Trading Up 9.8%

The stock has a market capitalization of $30.67 million, a P/E ratio of -5.57 and a beta of 0.94. The stock’s fifty day moving average price is $0.39 and its two-hundred day moving average price is $0.56.

Insider Buying and Selling at Milestone Scientific

In related news, major shareholder S.R.L. Bp4 sold 100,000 shares of the stock in a transaction dated Friday, October 24th. The stock was sold at an average price of $0.44, for a total transaction of $44,000.00. Following the completion of the sale, the insider directly owned 8,896,765 shares in the company, valued at $3,914,576.60. This represents a 1.11% decrease in their position. The sale was disclosed in a legal filing with the SEC, which is available through this link. Over the last three months, insiders sold 367,829 shares of company stock valued at $167,839. Insiders own 12.51% of the company’s stock.

Institutional Trading of Milestone Scientific

A number of institutional investors have recently modified their holdings of MLSS. XTX Topco Ltd grew its stake in shares of Milestone Scientific by 99.2% in the first quarter. XTX Topco Ltd now owns 34,135 shares of the company’s stock worth $32,000 after purchasing an additional 17,002 shares during the last quarter. Raymond James Financial Inc. lifted its holdings in Milestone Scientific by 416.7% in the 2nd quarter. Raymond James Financial Inc. now owns 62,000 shares of the company’s stock worth $39,000 after buying an additional 50,000 shares during the period. Finally, Carnegie Investment Counsel purchased a new stake in Milestone Scientific in the 2nd quarter worth approximately $105,000. 5.79% of the stock is currently owned by hedge funds and other institutional investors.

Milestone Scientific Company Profile

Milestone Scientific Inc, a biomedical technology research and development company, patents, designs, develops, and commercializes diagnostic and therapeutic injection technologies, and devices for medical, dental, and cosmetic use in the United States, China, and internationally. The company operates through Dental and Medical segments.